Immunohistochemical analysis of EGFR and hyaluronan in tongue cancer and the development of regional recurrence in patients initially diagnosed N0

被引:3
|
作者
Jonsson, Eva Lindell [1 ]
Nylander, Karin [2 ]
Hallen, Lars [3 ]
Laurell, Goran [1 ]
机构
[1] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
[2] Umea Univ, Dept Med Biosci, Umea, Sweden
[3] Umea Univ, Dept Clin Sci, Umea, Sweden
关键词
Epidermal growth factor receptor expression; immunoscoring; oral tongue squamous cell carcinoma; prognostic factors; biomarkers; SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; LYMPH-NODE METASTASIS; PROGNOSTIC-FACTOR; NECK METASTASIS; EXPRESSION; HEAD; BASE; RADIOTHERAPY; SURVIVAL;
D O I
10.1080/00016489.2017.1292049
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: To investigate whether the extent of expression of hyaluronan (HA) and epidermal growth factor receptor (EGFR) in squamous cell carcinoma of the mobile tongue can predict the risk of cervical metastasis and survival. Study design: Retrospective histopathologic study. Methods: Surgical specimens from 64 patients who had undergone surgery for squamous cell carcinoma of the mobile tongue were assessed using immunohistochemistry to investigate the expression of HA and EGFR in the primary tumours, and the data were then correlated to cervical metastasis and survival. Results: There was a significant correlation between the intensity of HA staining and patient survival (p .024), and a weak correlation between the staining proportion of EGFR and the risk for regional recurrence (AUC 66). Conclusions: This study indicates that immunoscoring using HA could be used to provide prognostic tools for tongue cancer, and that it might be of interest to study the prognostic properties of EGFR further concerning the risk for regional recurrence after the primary treatment.
引用
收藏
页码:877 / 882
页数:6
相关论文
共 50 条
  • [41] Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck—a meta-analysis comparing different imaging modalities
    Li-Jen Liao
    Wu-Chia Lo
    Wan-Lun Hsu
    Chi-Te Wang
    Mei-Shu Lai
    [J]. BMC Cancer, 12
  • [42] Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends
    Giovanni Conzo
    Ernesto Tartaglia
    Nicola Avenia
    Pier Giorgio Calò
    Annamaria de Bellis
    Katherine Esposito
    Claudio Gambardella
    Sergio Iorio
    Daniela Pasquali
    Luigi Santini
    Maria Antonia Sinisi
    Antonio Agostino Sinisi
    Mario Testini
    Andrea Polistena
    Giuseppe Bellastella
    [J]. World Journal of Surgical Oncology, 14
  • [43] Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends
    Conzo, Giovanni
    Tartaglia, Ernesto
    Avenia, Nicola
    Calo, Pier Giorgio
    de Bellis, Annamaria
    Esposito, Katherine
    Gambardella, Claudio
    Iorio, Sergio
    Pasquali, Daniela
    Santini, Luigi
    Sinisi, Maria Antonia
    Sinisi, Antonio Agostino
    Testini, Mario
    Polistena, Andrea
    Bellastella, Giuseppe
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14
  • [44] Comparison of recurrence-free survival according to axillary surgery extent for clinical N0, sentinel node(s) positive, primary breast cancer patients who underwent total mastectomy
    Chun, Jung Whan
    Kim, Hong-Kyu
    Lee, Han-Byoel
    Moon, Hyeong-Gon
    Lee, Jong Won
    Han, Wonshik
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [45] Establishing a risk stratification model to identify clinically high-risk N0 breast cancer who could benefit from regional nodal irradiation: a single institute analysis
    Qi, Wei-Xiang
    Cao, Lu
    Ou, Dan
    Li, Shuyan
    Xu, Cheng
    Cai, Rong
    Xu, Haoping
    Cai, Gang
    Chen, Jiayi
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [46] Comparison of clinical outcomes for patients with clinical N0 and pathologic N2 non-small cell lung cancer after thoracoscopic lobectomy and open lobectomy: A retrospective analysis of 76 patients
    Li, Yun
    Wang, Jung
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2012, 106 (04) : 431 - 435
  • [47] COMPARISON OF CLINICAL OUTCOMES FOR PATIENTS WITH CLINICAL N0 AND PATHOLOGIC N2 NON-SMALL CELL LUNG CANCER AFTER THORACOSCOPIC LOBECTOMY AND OPEN LOBECTOMY: A RETROSPECTIVE ANALYSIS OF 76 PATIENTS
    Li, Yun
    Wang, Jun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S131 - S131
  • [48] Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck-a meta-analysis comparing different imaging modalities
    Liao, Li-Jen
    Lo, Wu-Chia
    Hsu, Wan-Lun
    Wang, Chi-Te
    Lai, Mei-Shu
    [J]. BMC CANCER, 2012, 12
  • [49] Do we need to stage the axilla prior to neo adjuvant chemo? Analysis of clinically and radiologicaly negative (N0) breast cancer patients from a single centre
    Anwer, Abdul
    Salim, Mariam
    Shah, Fahd
    Pirzada, Muhammad
    Nasir, Irfan ul Islam
    Khan, Amina
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : 169 - 170
  • [50] Real-life analysis evaluating 1594 N0/Nmic breast cancer patients for whom treatment decisions incorporated the 21-gene recurrence score result: 5-year KM estimate for breast cancer specific survival with recurrence score results ≤30 is >98%
    Stemmer, S. M.
    Steiner, M.
    Rizel, S.
    Soussan-Gutman, L.
    Geffen, D. B.
    Nisenbaum, B.
    Ben-Baruch, N.
    Isaacs, K.
    Fried, G.
    Rosengarten, O.
    Uziely, B.
    Svedman, C.
    Rothney, M.
    Kiang, S. H.
    Ryvo, L.
    Kaufman, B.
    Evron, E.
    Zidan, J.
    Shak, S.
    Liebermann, N.
    [J]. CANCER RESEARCH, 2016, 76